Medivis
New York, US
Biotech
Founders & leadership
OC
Osamah ChoudhryExecutive Officer, Director
CM
Christopher MorleyExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$22MraisedSep 2022 · 25 investors · BiotechnologyRule 506(b)
▶$22MraisedSep 2022 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Osamah ChoudhryExecutive Officer, Director
- Christopher MorleyExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $22M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.